Thursday, April 24, 2014 Last update: 6:33 PM
Fast Breaking Live News = 100's of Daily Sales Leads

Science / Research News

Tuesday, April 8, 2014

  • Posted at 9:25 AM
    NMS Labs, a premier independent provider of professional forensic and clinical laboratory services, has announced the promotion of two key individuals on its executive leadership team. William S. Hough, Jr., who joined NMS Labs in May 2011 as Director of Human ... read more
  • Posted at 8:47 AM
    Racepoint Global, an advanced marketing services agency at the intersection of influence and action, today announced the launch of its life sciences practice, led by industry veteran Marla Kertzman, senior vice president. Racepoint ... read more
  • Posted at 8:17 AM
    In the bio for Alpaslan Yaman, his title should read: Alpaslan Yaman, Ph.D., Vice President, Operations and Manufacturing The corrected release reads: EDGE THERAPEUTICS EXPANDS SENIOR MANAGEMENT TEAM AND OPENS NEW HEADQUARTERS TO ... read more
  • Posted at 8:06 AM
    Cmed, a full service CRO specialized in the design and delivery of both innovative and traditional early phase I to IIb patient clinical trials, has been invited to share its early phase clinical research expertise at leading industry events in the coming months. ... read more
  • Posted at 6:17 AM
    Agere Pharmaceuticals, Inc., a leading CDMO and innovator in oral bioavailability solutions announced today that R. Brendt Stallings has joined the company’s board of directors. Mr. Stallings is an executive vice president at DoubleLine Capital, LLP, and a founding partner at DoubleLine Equity LP. He was ... read more
  • Posted at 6:02 AM
    ReFlow Medical, Inc. (ReFlow) today announced that it has signed an exclusive distribution and sales agreement for ReFlow's suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo), a division of MicroPort Scientific Corporation (MicroPort), a leading ... read more
  • Posted at 6:00 AM
    Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions, today announced the appointment and promotion of key executives to its senior management ... read more
  • Posted at 6:00 AM
    A physician-initiated, double-blind, randomized, placebo-controlled clinical trial comparing the intravesical instillation of a topical botulinum toxin type A formulation (LP-09) to placebo in 24 subjects diagnosed with overactive bladder (OAB) showed significant reductions in both urinary urgency and urinary frequency. This result, published in European ... read more
  • Posted at 5:08 AM
    Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, today announced that it has filed its annual report containing audited consolidated financial statements for the year ended December 31, 2013 with the United States Securities ... read more
  • Posted at 5:00 AM
    Mitralign Inc., a cardiac device company, announced today it has completed enrollment in a study in Europe investigating its lead device, the Mitralign System, in patients with functional mitral regurgitation (FMR). Pending successful outcomes from the study, the company will seek ... read more

Monday, April 7, 2014